vaccine-efficacy

Documents about vaccine-efficacy

• Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria#856202ClinicalTrials.gov
• Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients#967047ClinicalTrials.gov
• A newly developed oral infection mouse model of shigellosis for immunogenicity and protective efficacy studies of a candidate vaccine#379022OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study#825738ClinicalTrials.gov
• A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age#899595ClinicalTrials.gov
• Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza#160187ClinicalTrials.gov
• Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine#123461ClinicalTrials.gov
• Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study#136437ClinicalTrials.gov
• Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients#141090ClinicalTrials.gov
• Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)#217100ClinicalTrials.gov
• Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)#321550ClinicalTrials.gov
• Simulation of synthetic health records for assessment of causal inference methods for vaccine efficacy#448648Europe PMC
• Estimating Vaccine Efficacy in Stochastic SIR Epidemic Models with Non Homogeneous Mixing#493638Cornell eCommons
• Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response#628541ClinicalTrials.gov
• Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection#683122ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine#995107ClinicalTrials.gov
• Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30#805233ClinicalTrials.gov
• Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19#867589ClinicalTrials.gov
• A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa#1030693ClinicalTrials.gov
• Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)#148589ClinicalTrials.gov
• From Crisis to Control: A Study of Typhoid Conjugate Vaccine Efficacy in Harare, Zimbabwe (2017–2024)#185025DORAS
• ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.#199154NCBI PubMed Central
• Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine#349405WIReDSpace
• Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults#369877ClinicalTrials.gov
• Comprehensive Evaluation of the Efficacy and Safety of the Clostridioides difficile Toxoid Vaccine: A Meta-Analysis.#418300NCBI PubMed Central
• Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults#429615ClinicalTrials.gov
• Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults#451515ClinicalTrials.gov
• Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years#902133ClinicalTrials.gov
• Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy#908221ClinicalTrials.gov
• Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.#67667ClinicalTrials.gov
• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne#148579ClinicalTrials.gov
• Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer#152497ClinicalTrials.gov
• Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells#190314Ora Oxford University Research
• Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma#234510ClinicalTrials.gov
• Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).#283114ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria#343684ClinicalTrials.gov
• A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI#373646ClinicalTrials.gov
• A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine#414353ClinicalTrials.gov
• Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants#444769ClinicalTrials.gov
• Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi#471505ClinicalTrials.gov
• Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil#623562ClinicalTrials.gov
• A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine#633755ClinicalTrials.gov
• Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers#903956ClinicalTrials.gov
• A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children#234481ClinicalTrials.gov
• Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.#409749PubMed
• One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.#67686ClinicalTrials.gov
• A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults#146276ClinicalTrials.gov
• Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults#195400ClinicalTrials.gov
• Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)#195404ClinicalTrials.gov
• Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women#300321ClinicalTrials.gov